In agreement with the previous studies, where BRCA1 mutations, which predispose to TNBC have been found to have increased ROS levels, our data shows increased ROS levels in all the TNBC cell lines studied in comparison to an ER+ breast cancer cell line or the non-tumorigenic cells. Here, BRCA1 is linked to breast carcinoma.